The patient was enrolled in the coaptite injectable implant study for stress urinary incontinence.On (b)(6) 2012 the patient was injected with 3.0ml of coaptite, lots 1032138 & 1031015.No adverse event reported.On (b)(6) 2012 the patient was injected with 4.0ml of coaptite, lots 1034173, 1032763, 1032765.On (b)(6) 2014 the patient reported a urinary tract infection.On (b)(6) 2014 the patient was prescribed antibiotic treatment by her primary care physician (name of antibiotic, dose & duration unknown).The physician assessed the event as mild and definitely not device related.
|